Phase 1b investigation of the MEK inhibitor binimetinib in patients with advance
- This topic has 0 replies, 1 voice, and was last updated 6 years, 3 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer.
https://www.ncbi.nlm.nih.gov/pubmed/29785570
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.